Skip to main content
Swing Capital

Medicamen Biotech Ltd

NSE: MEDICAMEQ BSE: 531146Pharma

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]

₹267
52W: ₹217 — ₹456
PE 41 · Book ₹201 · +33% vs book
Market Cap₹363 Cr
Stock P/E41Price to Earnings
ROCE6.77%Return on Capital
ROE4.43%Return on Equity
Div. Yield0.35%Face Value ₹10

Weaknesses

  • −The company has delivered a poor sales growth of 5.24% over past five years.
  • −Company has a low return on equity of 6.45% over last 3 years.
  • −Earnings include an other income of Rs.6.59 Cr.
  • −Dividend payout has been low at 10.5% of profits over last 3 years

Shareholding Pattern

Promoters40.46%
FIIs0.1%
DIIs0%
Public59.39%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters42.99%42.99%42.99%43.16%▲0.240.46%▼2.740.46%40.46%40.46%
FIIs0.06%0.06%0.06%0.12%▲0.10%▼0.10.05%▲0.10.02%▼0.00.1%▲0.1
DIIs1.17%1.17%0.87%▼0.30.69%▼0.20.64%▼0.00.59%▼0.10.44%▼0.10%▼0.4
Public55.78%55.79%▲0.056.04%▲0.355.99%▼0.058.83%▲2.858.84%▲0.059.02%▲0.259.39%▲0.4

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales42.6744.245.0141.4842.8441.142638.4542.2343.49
Expenses36.5138.6138.1836.6236.2934.927.134.4237.1838.41
Operating Profit6.165.596.834.866.556.24-1.14.035.055.08
OPM %14.44%12.65%15.17%11.72%15.29%15.17%-4.23%10.48%11.96%11.68%
Net Profit3.012.773.12.262.272.522.41.642.212.59
EPS ₹2.382.192.441.781.791.981.891.211.631.91

AI Insights

Revenue Trend

TTM revenue at ₹150Cr, down 0.7% YoY. OPM at 9%.

Debt Position

Borrowings at ₹31Cr. Debt-to-equity ratio: 0.12x. Healthy balance sheet.

Institutional Flow

DIIs: 0% (-0.20pp change). FIIs: 0.1% (-0.06pp change). Promoters hold 40.46%.

Margin & Efficiency

ROCE declining from 13% (Mar 2014) to 7% (Mar 2025). Working capital days: 186.

Valuation

PE 41x with 6.77% ROCE. Price is 33% above book value of ₹201. Dividend yield: 0.35%.

Recent Announcements